Cargando…
Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
The immune checkpoint blockade therapy has drastically advanced treatment of different types of cancer over the past few years. Female breast cancer is the second leading cause of death in the overall burden of cancers worldwide that is encouraging healthcare professionals to improve cancer care man...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089925/ https://www.ncbi.nlm.nih.gov/pubmed/32258038 http://dx.doi.org/10.3389/fcell.2020.00162 |